Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Newsom-Davis

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
JTO Clinical and Research Reports|March 19, 2026
Definitive Radiotherapy With or Without Chemotherapy After Planned Neoadjuvant Chemoimmunotherapy in Stages II to III NSCLC: An International Multicenter Retrospective StudyElio Adib, Amin H Nassar, Katie N Lee, et al.
Journal for Immunotherapy of Cancer|February 17, 2022
Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinationsAlessio Cortellini, Biagio Ricciuti, Victor R Vaz, et al.
Cancers|July 12, 2020
Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in EuropeDavid J Pinato, Alvin J X Lee, Federica Biello, et al.
Lancet (London, England)|June 1, 2020
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort studyLennard Yw Lee, Jean-Baptiste Cazier, Vasileios Angelis, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 29, 2023
Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registryAnahita Mostaghim, Samuel Minkove, Juan Aguilar-Company, et al.
Therapeutic Advances in Medical Oncology|September 9, 2021
Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspectiveGehan Soosaipillai, Anjui Wu, Gino M Dettorre, et al.
The Lancet. Oncology|June 6, 2022
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry studyDavid J Pinato, Juan Aguilar-Company, Daniela Ferrante, et al.
Therapeutic Advances in Medical Oncology|November 15, 2021
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registryLaia Garrigós, Cristina Saura, Clara Martinez-Vila, et al.
Cancer Discovery|August 2, 2020
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patientsDavid J Pinato, Alberto Zambelli, Juan Aguilar-Company, et al.
The Lancet. Oncology|March 10, 2023
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registryAlessio Cortellini, Josep Tabernero, Uma Mukherjee, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
JTO Clinical and Research Reports|March 19, 2026
Definitive Radiotherapy With or Without Chemotherapy After Planned Neoadjuvant Chemoimmunotherapy in Stages II to III NSCLC: An International Multicenter Retrospective StudyElio Adib, Amin H Nassar, Katie N Lee, et al.
Journal for Immunotherapy of Cancer|February 17, 2022
Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinationsAlessio Cortellini, Biagio Ricciuti, Victor R Vaz, et al.
Cancers|July 12, 2020
Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in EuropeDavid J Pinato, Alvin J X Lee, Federica Biello, et al.
Lancet (London, England)|June 1, 2020
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort studyLennard Yw Lee, Jean-Baptiste Cazier, Vasileios Angelis, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 29, 2023
Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registryAnahita Mostaghim, Samuel Minkove, Juan Aguilar-Company, et al.
Therapeutic Advances in Medical Oncology|September 9, 2021
Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspectiveGehan Soosaipillai, Anjui Wu, Gino M Dettorre, et al.
The Lancet. Oncology|June 6, 2022
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry studyDavid J Pinato, Juan Aguilar-Company, Daniela Ferrante, et al.
Therapeutic Advances in Medical Oncology|November 15, 2021
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registryLaia Garrigós, Cristina Saura, Clara Martinez-Vila, et al.
Cancer Discovery|August 2, 2020
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patientsDavid J Pinato, Alberto Zambelli, Juan Aguilar-Company, et al.
The Lancet. Oncology|March 10, 2023
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registryAlessio Cortellini, Josep Tabernero, Uma Mukherjee, et al.
Pageof 4